Drug Approval | June 08, 2023
European Commission authorises GSK’s Arexvy for older adults
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
he product will be launched shortly in the US market.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Subscribe To Our Newsletter & Stay Updated
